Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Therapy-Related Myelodysplastic Syndrome”

113 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 113 results

Testing effectiveness (Phase 2)Study completedNCT02500550
What this trial is testing

Safety and Efficacy of Two Doses of ATIR101, a T-lymphocyte Enriched Leukocyte Preparation Depleted of Host Alloreactive T-cells, in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical Donor

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic Syndrome
Kiadis Pharma 15
Large-scale testing (Phase 3)Ended earlyNCT02999854
What this trial is testing

Safety and Efficacy of ATIR101 as Adjunctive Treatment to Blood Stem Cell Transplantation From a Haploidentical Family Donor Compared to Post-transplant Cyclophosphamide in Patients With Blood Cancer

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic Syndrome
Kiadis Pharma 63
Not applicableStudy completedNCT06143839
What this trial is testing

VYxeoS Liposomal Italian Observational Study iN the Real Practice

Who this might be right for
Acute Myeloid Leukemia (AML)Acute Myeloid Leukemia With Myelodysplasia-Related ChangesTherapy-Related Acute Myeloid Leukemia
Jazz Pharmaceuticals 113
Not applicableWithdrawnNCT00499668
What this trial is testing

Aprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With Cancer

Who this might be right for
Myeloproliferative DisordersLeukemiaLymphoma+5 more
Vanderbilt-Ingram Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00582933
What this trial is testing

Phase II Trial of a Chemotherapy Alone Regimen of IV Busulfan (Busulfex), Melphalan and Fludarabine as Myeloablative Regimen Followed by an Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplant From an HLA-Identical, or HLA-Non Identical Related or Unrelated Donor

Who this might be right for
LeukemiaMyelodysplastic SyndromeNon-Hodgkin's Lymphoma+1 more
Memorial Sloan Kettering Cancer Center 96
Large-scale testing (Phase 3)Study completedNCT00003687
What this trial is testing

Treatment for Chronic Pain in Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+6 more
NCIC Clinical Trials Group 87
Testing effectiveness (Phase 2)Ended earlyNCT02438761
What this trial is testing

PF-05212384 (PKI-587) for t-AML/MDS or de Novo Relapsed or Refractory Acute Myeloid Leukemia (AML) (LAM-PIK)

Who this might be right for
Therapy-related Acute Myeloid Leukemia and Myelodysplastic SyndromeAcute Myeloid Leukemia, in Relapsede Novo Acute Myeloid Leukemia at Diagnostic
Institut Curie 10
Large-scale testing (Phase 3)Active Not RecruitingNCT05316701
What this trial is testing

Precision-T: A Randomized Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoid LeukemiaMixed Phenotype Acute Leukemia+4 more
Orca Biosystems, Inc. 187
Testing effectiveness (Phase 2)Study completedNCT04926194
What this trial is testing

Decidual Stromal Cells to Treat Graft-vs-Host Disease After Stem Cell Transplant for Myelodysplastic Syndrome/Myeloproliferative Neoplasm

Who this might be right for
Myelodysplastic/Myeloproliferative NeoplasmSteroid Refractory GVHDAllogeneic Hematopoietic Cell Transplant
University Health Network, Toronto 1
Not applicableStudy completedNCT00951626
What this trial is testing

A Standardized Nursing Intervention Protocol for HCT Patients

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+5 more
City of Hope Medical Center 282
Not applicableLooking for participantsNCT06956755
What this trial is testing

Registry of Myelodysplastic Syndromes and Therapy-related Acute Myeloid Leukemia

Who this might be right for
Myelodysplastic SyndromesLeukemia, Myeloid, Acute
Groupe Francophone des Myelodysplasies 6,990
Not applicableUnknownNCT00525746
What this trial is testing

Molecular Epidemiology of Therapy-related Acute Myeloid Leukemia/Myelodysplastic Syndrome (AML/MDS)

Who this might be right for
LeukemiaMyelodysplastic Syndrome
M.D. Anderson Cancer Center 191
Testing effectiveness (Phase 2)Study completedNCT01119066
What this trial is testing

HLA-Compatible Related or Unrelated Donors With CD34+ Enriched, T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System in the Treatment of Patients With Hematologic Malignancies

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaMyelodysplastic Syndrome+1 more
Memorial Sloan Kettering Cancer Center 422
Early research (Phase 1)Study completedNCT01130506
What this trial is testing

Decitabine, Vorinostat, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome

Who this might be right for
Previously Treated Myelodysplastic SyndromeRecurrent Adult Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia+3 more
National Cancer Institute (NCI) 17
Testing effectiveness (Phase 2)Looking for participantsNCT04644016
What this trial is testing

Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders

Who this might be right for
AMLALLMDS+6 more
Memorial Sloan Kettering Cancer Center 31
Large-scale testing (Phase 3)Study completedNCT00005805
What this trial is testing

St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer

Who this might be right for
Chronic Myeloproliferative DisordersFatigueLeukemia+5 more
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00618969
What this trial is testing

Peripheral Blood Stem Cell Transplantation (PBSCT)From Haploidentical Related Donors

Who this might be right for
Hematologic NeoplasmsAnemia, AplasticHemoglobinuria, Paroxysmal+1 more
University of Arizona 2
Early research (Phase 1)Study completedNCT00003395
What this trial is testing

Arsenic Trioxide in Treating Patients With Advanced Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00587054
What this trial is testing

Trial of Allogeneic Stem Cell Transplants From HLA Compatible, Related and Unrelated Donors After a Myeloablative Preparative Regimen With Hyperfractionated TBI, Thiotepa and Fludarabine For Adult Patients With Lymphohematopoietic Disorders

Who this might be right for
Allogeneic Stem Cell TransplantLeukemiaNon-Hodgkins+3 more
Memorial Sloan Kettering Cancer Center 129
Early research (Phase 1)UnknownNCT00004036
What this trial is testing

Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersDrug/Agent Toxicity by Tissue/OrganLeukemia+5 more
The Cleveland Clinic 30
Load More Results